These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12642174)

  • 1. Effect of postnatal iron administration on MPTP-induced behavioral deficits and neurotoxicity: behavioral enhancement by L-Dopa-MK-801 co-administration.
    Fredriksson A; Archer T
    Behav Brain Res; 2003 Feb; 139(1-2):31-46. PubMed ID: 12642174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postnatal iron overload destroys NA-DA functional interactions.
    Fredriksson A; Archer T
    J Neural Transm (Vienna); 2007 Feb; 114(2):195-203. PubMed ID: 16932993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-administration of memantine and amantadine with sub/suprathreshold doses of L-Dopa restores motor behaviour of MPTP-treated mice.
    Fredriksson A; Danysz W; Quack G; Archer T
    J Neural Transm (Vienna); 2001; 108(2):167-87. PubMed ID: 11314771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional alteration by NMDA antagonist: effects of L-Dopa, neuroleptics drug and postnatal administration.
    Fredriksson A; Archer T
    Amino Acids; 2002; 23(1-3):111-32. PubMed ID: 12373526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of noradrenaline denervation on MPTP-induced deficits in mice.
    Archer T; Fredriksson A
    J Neural Transm (Vienna); 2006 Sep; 113(9):1119-29. PubMed ID: 16362627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic interactions between NMDA-antagonists and L-dopa on activity in MPTP-treated mice.
    Fredriksson A; Gentsch C; Archer T
    J Neural Transm Gen Sect; 1994; 97(3):197-209. PubMed ID: 7873129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of co-administration of anticonvulsant and putative anticonvulsive agents and sub/suprathreshold doses of L-dopa upon motor behaviour of MPTP-treated mice.
    Fredriksson A; Palomo T; Archer T
    J Neural Transm (Vienna); 1999; 106(9-10):889-909. PubMed ID: 10599871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance to a suprathreshold dose of L-Dopa in MPTP mice: effects of glutamate antagonists.
    Fredriksson A; Palomo T; Chase T; Archer T
    J Neural Transm (Vienna); 1999; 106(3-4):283-300. PubMed ID: 10392537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MPTP-induced hypoactivity in mice: reversal by L-dopa.
    Fredriksson A; Plaznik A; Sundström E; Jonsson G; Archer T
    Pharmacol Toxicol; 1990 Oct; 67(4):295-301. PubMed ID: 2077520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of MAO inhibitors upon MPTP mice chronically treated with suprathreshold doses of L-dopa.
    Fredriksson A; Palomo T; Archer T
    Behav Pharmacol; 2000 Nov; 11(7-8):571-81. PubMed ID: 11198128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional consequences of iron overload in catecholaminergic interactions: the Youdim factor.
    Archer T; Fredriksson A
    Neurochem Res; 2007 Oct; 32(10):1625-39. PubMed ID: 17694434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postnatal iron-induced motor behaviour alterations following chronic neuroleptic administration in mice.
    Fredriksson A; Eriksson P; Archer T
    J Neural Transm (Vienna); 2006 Feb; 113(2):137-50. PubMed ID: 16082515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maze learning and motor activity deficits in adult mice induced by iron exposure during a critical postnatal period.
    Fredriksson A; Schröder N; Eriksson P; Izquierdo I; Archer T
    Brain Res Dev Brain Res; 2000 Jan; 119(1):65-74. PubMed ID: 10648873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antihypokinesic action of alpha2-adrenoceptors upon MPTP-induced behaviour deficits in mice.
    Archer T; Fredriksson A
    J Neural Transm (Vienna); 2003 Feb; 110(2):183-200. PubMed ID: 12589577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits.
    Fredriksson A; Schröder N; Eriksson P; Izquierdo I; Archer T
    Parkinsonism Relat Disord; 2001 Apr; 7(2):97-105. PubMed ID: 11248590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice.
    Fredriksson A; Archer T
    Neurotox Res; 2006 Oct; 10(2):123-9. PubMed ID: 17062374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in mice.
    Fredriksson A; Archer T
    Neurotox Res; 2006 Jun; 9(4):305-12. PubMed ID: 16782590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperactivity following postnatal NMDA antagonist treatment: reversal by D-amphetamine.
    Fredriksson A; Archer T
    Neurotox Res; 2003; 5(7):549-64. PubMed ID: 14715439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic interactions between COMT-/MAO-inhibitors and L-Dopa in MPTP-treated mice.
    Fredriksson A; Archer T
    J Neural Transm Gen Sect; 1995; 102(1):19-34. PubMed ID: 8785021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed common marmosets.
    Iravani MM; Costa S; Jackson MJ; Tel BC; Cannizzaro C; Pearce RK; Jenner P
    Eur J Neurosci; 2001 Feb; 13(3):597-608. PubMed ID: 11168568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.